Publications | Real-World Evidence

19.03.2025

Data on Ocrelizumab treatment collected by MS patients in Germany using Brisa app

Leveraging real-world data from the Brisa app, this study reveals how detailed, patient-reported insights on ocrelizumab treatment can bridge the gap between clinical research and everyday MS care—empowering more personalized, data-driven treatment strategies. Steffeni Papukchieva, Maria Kahn, Marku...

Real-World Evidence Multiple Sclerosis

Read publication

19.03.2025

Real-world evidence from Germany and the United States: Treatment initiation on low-efficacy versus high-efficacy therapies in patients with multiple sclerosis

Real-world evidence from Germany and the US shows that initiating MS treatment with high-efficacy therapies reduces the need for switching treatments—unlocking more stable, effective long-term disease management and transforming patient outcomes. By Steffeni Papukchieva, Hyung-Do Kim, Ann-Sophie Str...

Real-World Evidence Multiple Sclerosis

Read publication

28.06.2024

Diagnostic delay in Hidradenitis Suppurativa investigated using data from social media and from statutory health insurances

this study reveals how prolonged diagnostic delays in hidradenitis suppurativa not only burden patients with reduced work capacity and diminished quality of life but also highlight actionable opportunities to streamline interdisciplinary care. Discover how earlier diagnosis can transform patient out...

Patient Conversations Real-World Evidence

Read publication

Medical Publications

Stay informed on new healthcare insights!

We are at the dawn of a new healthcare era.

Medical Publications

Related resources

Stay informed on new healthcare insights!

We are at the dawn of a new healthcare era.